ZA971134B - Multifunctional fat absorption and blood cholesterol reducing formulation. - Google Patents

Multifunctional fat absorption and blood cholesterol reducing formulation.

Info

Publication number
ZA971134B
ZA971134B ZA9701134A ZA971134A ZA971134B ZA 971134 B ZA971134 B ZA 971134B ZA 9701134 A ZA9701134 A ZA 9701134A ZA 971134 A ZA971134 A ZA 971134A ZA 971134 B ZA971134 B ZA 971134B
Authority
ZA
South Africa
Prior art keywords
acid
blood cholesterol
fat absorption
cholesterol reducing
reducing formulation
Prior art date
Application number
ZA9701134A
Other languages
English (en)
Inventor
Ivan Furda
Original Assignee
Ivan Furda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivan Furda filed Critical Ivan Furda
Publication of ZA971134B publication Critical patent/ZA971134B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA9701134A 1996-02-14 1997-02-11 Multifunctional fat absorption and blood cholesterol reducing formulation. ZA971134B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/601,388 US5736532A (en) 1996-02-14 1996-02-14 Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan

Publications (1)

Publication Number Publication Date
ZA971134B true ZA971134B (en) 1997-08-25

Family

ID=24407295

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701134A ZA971134B (en) 1996-02-14 1997-02-11 Multifunctional fat absorption and blood cholesterol reducing formulation.

Country Status (10)

Country Link
US (1) US5736532A (de)
EP (1) EP0881903B1 (de)
JP (1) JP2000504724A (de)
AT (1) ATE238805T1 (de)
AU (1) AU1852597A (de)
DE (1) DE69721497T2 (de)
ES (1) ES2199342T3 (de)
ID (1) ID15895A (de)
WO (1) WO1997029760A1 (de)
ZA (1) ZA971134B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1100344T3 (da) 1998-07-30 2004-10-11 Vital Living Inc Chitosanholdige flydende præparater og fremgangsmåder til deres fremstilling og anvendelse
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
WO2003013471A2 (en) * 2001-08-08 2003-02-20 Paolina Galvao Pharmaceutical enteric coated composition comprising chitosan
US6897348B2 (en) 2001-12-19 2005-05-24 Kimberly Clark Worldwide, Inc Bandage, methods of producing and using same
US7419655B2 (en) * 2002-09-11 2008-09-02 Kimberly-Clark Worldwide, Inc. Skin care products
GB0302741D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Use
RU2232775C1 (ru) * 2003-05-16 2004-07-20 Общество с ограниченной ответственностью "Инвест-Фарм" Способ получения ионосвязанных производных олигосахарида хитозана
US20070116713A1 (en) * 2005-11-22 2007-05-24 Gill Robert P Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR100882611B1 (ko) * 2006-11-14 2009-02-12 주식회사 키토라이프 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법
US7659313B2 (en) 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
CN102469782A (zh) 2010-06-18 2012-05-23 哈洛资源公司 包含壳聚糖的固态共混物的制剂及方法
JP6855165B2 (ja) * 2012-06-15 2021-04-07 コナリス リサーチ インスティチュート アーゲー ニコチン酸および／もしくはニコチンアミドならびに／またはトリプトファンを含有する、腸内微生物叢によい影響を及ぼすための医薬組成物
WO2015086838A2 (en) * 2013-12-13 2015-06-18 Conaris Research Institute Ag A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
EP3079675B1 (de) 2013-12-13 2020-02-12 CONARIS research institute AG Pharmazeutische zusammensetzung mit nicotinsäure und/oder nicotinamid zur verwendung zur vorteilhaften beeinflussung von blutlipidspiegeln durch modifizierung der darmmikrobiota
ITUA20161937A1 (it) * 2016-03-23 2017-09-23 S I I T S R L Servizio Int Imballaggi Termosaldanti Preparazione per il controllo del peso corporeo a base di chitosano e cellulosa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives

Also Published As

Publication number Publication date
ID15895A (id) 1997-08-14
EP0881903B1 (de) 2003-05-02
US5736532A (en) 1998-04-07
DE69721497T2 (de) 2004-03-18
WO1997029760A1 (en) 1997-08-21
EP0881903A1 (de) 1998-12-09
ES2199342T3 (es) 2004-02-16
DE69721497D1 (de) 2003-06-05
ATE238805T1 (de) 2003-05-15
AU1852597A (en) 1997-09-02
JP2000504724A (ja) 2000-04-18

Similar Documents

Publication Publication Date Title
ZA971134B (en) Multifunctional fat absorption and blood cholesterol reducing formulation.
KR920000324A (ko) 필수 지방산 처리법
MY122501A (en) Lactobacilli to increase absorption of minerals by intestinal cells
EP0903143A3 (de) Verwendung von Daidzein zur Herstellung eines Arzneimittels zur Erhöhung des HDL Cholesterolniveaus
DE69314035D1 (de) Verbesserte aushalten - und rehydratationzusammenstellung
ATE236627T1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
NO20023684L (no) Pediatrisk formulering
AU2989695A (en) Pharmaceutically stable oxaliplatinum preparation
EP0440341A1 (de) Zusammensetzungen essentieller Fettsäuren und Therapie
CA2136614A1 (en) Nitrous oxide containing dermatological composition
AU4185696A (en) Increasing creatine and glycogen concentration in muscle
PL319585A1 (en) Vitamins and calcium, containing therapeutic composition in the unit galenic form of tablets, method of obtaining same and application thereof
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
WO2001019356A3 (en) High lipid diet
WO2000041504A3 (en) Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
CS545686A1 (en) Farmaceuticky prostredek a antihepatotoxickym pusobenim
CA2387787A1 (en) Nutritional composition for treating inflammatory bowel diseases
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
RO116343B1 (ro) Compoziţie farmaceutică şi metodă de tratament a infecţiilor bacteriene la pacienţi pediatrici
AU1300001A (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
SE9801647D0 (sv) Therapeutic composition
EP0344997A3 (de) Verwendung von Phytinsäure oder eines ihrer Salze als Aktivator für hypoxysche Zellen und als Durchblutungsförderer
BG104286A (en) Composition for the suppression of the symptoms of withdrawal and irresistible desire for alcohol in alcoholics and prevention of alcohol addiction among healthy patients
CA2067243A1 (en) Compositions and methods for weight reduction